TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive Guest Editorial: caBIG Has Another Fundamental Problem: It Relies On “Incoherent” Messaging Standard April 22, 2011
TCL Archive Amid Protests Over Grant Paylines, NCI’s Niederhuber Tells Scientists To Get “Leaner And Better”. April 7, 2006
